REQUEST A DEMO
Total
USD $0.00
Search more companies

New Life Pharmaceutical Company Limited (Thailand)

Main Activities: Pharmacies and Drug Stores
Full name: New Life Pharmaceutical Company Limited Profile Updated: March 31, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English Download a sample report

New Life Pharmaceutical Company Limited is based in Thailand. The head office is in Chachoengsao. The enterprise operates in the Pharmacies and Drug Stores industry. The company was established on May 20, 2026. The total number of employees is currently 21 (estimated). The latest financial highlights indicate a net sales revenue drop of 30.58% in 2024. Its’ total assets recorded a growth of 6.33%. The enterprise’s net profit margin decreased by 3.66% in 2024.

Headquarters
99/3 Moo 1
Chachoengsao; Eastern Thailand; Postal Code: 24120

Contact Details: Purchase the New Life Pharmaceutical Company Limited report to view the information.

Basic Information
Total Employees:
Purchase the New Life Pharmaceutical Company Limited report to view the information.
Financial Auditors:
Purchase the New Life Pharmaceutical Company Limited report to view the information.
Incorporation Date:
May 20, 2026
Key Executives
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Company Performance
Financial values in the chart are available after New Life Pharmaceutical Company Limited report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency THB. Absolute financial data is included in the purchased report.
Net sales revenue
-30.58%
Total Operating Revenue
-30.6%
Operating Profit
-49.56%
EBITDA
-49.56%
Net Profit/Loss for the Period
-49.76%
Total Assets
6.33%
Total Equity
15.78%
Operating Profit Margin
-4.52%
Net Profit Margin
-3.66%
Return on Equity (ROE)
-17.78%
Debt / Equity
-7.18%
Quick Ratio
13.53%
Cash Ratio
-0.05%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?